Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
The National Institute of Neurological Disorders and Stroke (NINDS) and the National Institutes of Health (NIH) are announcing a new funding opportunity for scientific research using data from expanded access to investigational drugs or biological products for patients with amyotrophic lateral sclerosis (ALS). This opportunity focuses on those who cannot join regular clinical trials. The resea…
Source
Dates
Keywords
Supporting Links
Documents
Similar Opportunities
Get the full picture on this opportunity
Create a free Scout account to unlock everything you need to decide fast and win the grant.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Deep agency & funder detail
Program context, sub-agency structure, and a full eligibility breakdown.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Similar opportunities
Discover related funding matched to your work.
Already have an account? Sign In
Trusted by 500+ Happy Customers